Ulta Beauty grants CFO stock options and shares
Ulta Beauty’s Chief Financial Officer Christopher DelOrefice received new equity awards as part of his compensation.
Rhea-AI Filing Summary
Ulta Beauty’s Chief Financial Officer Christopher DelOrefice received new equity awards as part of his compensation. He was granted 4,219 shares of restricted stock that vest 100% on March 15, 2029, giving him more direct ownership over time.
He was also granted stock options covering 14,363 shares of common stock at an exercise price of $522.71 per share. These options vest in 25% annual increments beginning March 15, 2027 and on each anniversary through March 15, 2030, and expire on March 31, 2036. Following the grants, he directly holds 9,693 shares of common stock, plus the new option award.
Positive
- None.
Negative
- None.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (right to buy) | 14,363 | $0.00 | $0.00 |
| Grant/Award | Common Stock | 4,219 | $0.00 | $0.00 |
Footnotes (2)
- F1. Represents grant of 4,219 shares of restricted stock, vesting 100% on March 15, 2029.
- F2. The options, representing an initial right to purchase a total of 14,363 shares, vesting in 25% annual increments beginning March 15, 2027 and each anniversary thereafter through March 15, 2030.
Key Figures
Key Terms
restricted stock financial
Stock Option (right to buy financial
vesting financial
exercise price financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did Ulta Beauty (ULTA) disclose about its CFO in this Form 4?
What stock options were granted to Ulta Beauty (ULTA) CFO Christopher DelOrefice?
How do the Ulta Beauty CFO stock options vest over time?
Are the Ulta Beauty CFO transactions in this Form 4 open-market buys or sells?
AI-generated analysis. How Rhea-AI works. Not financial advice.